Scimplify, an innovative enterprise in the chemical sector, recently announced the completion of round B financing and successfully received a capital injection of 40 million us dollars. From what I've seen, This round of financing is jointly led by multinational capital Accel and Bertelsmann India Investment Company, followed by established investors such as UMI, Omnivore and 3one4 Capital. Pretty interesting, huh?. it's worth noting that after Bertelsmann's first capital injection last year, this additional investment shows the institution'strong confidence in its research prospects. data show that the enterprise has completed a total of 54 million US dollars in financing from seed round to round B, of which
13. 5 million US dollars were obtained in the early financing stage. The newly obtained capital will focus on the expansion of the global business network. At present, its service network has covered 16 crucial manufacturing markets, including the United States, Europe and Japan, covering three core areas of life sciences, crop protection and manufacturing chemicals. In the face of the long-standing structural contradiction in the global specialty chemicals sector-the coexistence of excess stock and demand gap, Scimplify has created a "research studies-manufacturing" collaborative system. Sachin Santhosh, co-founder of the enterprise, pointed out: "Traditional manufacturing facilities generally have a dual-track dilemma of lack of research and research capabilities and low capacity utilization. In fact We have built a dynamically adjustable manufacturing ecology by connecting greater than 200 professional factories with top research studies teams. "
the platform's original collaboration model to efficiently solve the sector's pain points: not only to prevent heavy asset investment, however also to rapidly respond to changes in market demand. But According to the person in charge of the methodology, its Hyderabad R & D center has formed a complete methodology transformation system, which is able to realize extensive mass production of laboratory results within 45 days, which is 60% shorter than the traditional model. Generally speaking Rachit Parekh, head of Accel,'s lead investor, stressed: "In the global context of supply chain restructuring, Scimplify's R & D-driven network shows unique value. Their success in combining the manufacturing advantages of India with cutting-edge research studies capabilities is the key to our continued optimism. And "Rohit Sood, partner of Bertelsmann India, especially appreciated its implementation ability:" The team not only achieved an average annual revenue development of 200 per cent, however also established an intelligent supply chain network covering many countries. Based on my observations, "
According to the enterprise research plan, this round of financing will focus on three aspects: 1) R & D center expansion, new manufacturing catalytic processes, polymer synthesis and other laboratories; 2) European production base construction, enhance the global supply chain layout; 3) expand electronic chemicals and other emerging areas. The company expects to expand to 30 countries in the next three years and increase its annual production capacity to five times the current one. sector observers pointed out that the "chemical sector cloud platform" model Scimplify is building might trigger a paradigm shift in global specialty chemicals manufacturing. Specifically Through the digital integration of scattered R & D and manufacturing resources, the platform has solved greater than 1200 complex chemical synthesis problems to global customers, demonstrating strong manufacturing integration capabilities.